EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactate Metabolism‐Immune Regulation‐Related Gene Signature in Lower‐Grade Gliomas: Prognostic Model Development and Immune Characterization

Enhao Zhang iD, Liangzhe Wei, He Ren, Jianfei Zhang, Hongqiao Yang, Meng Sun, Xiang Gao, Yi Huang iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202503738rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Enhao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Key Laboratory of Nervous System and Brain Function, Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, Z…. Hauptthemen laut MEDLINE: Glioma, Gene Expression Regulation, Neoplastic, Brain Neoplasms, Lactic Acid. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningbo Top Medical and Health Research Program, Ningbo Natural Science Foundation, Ningbo Municipal Youth Science and Technology Innovation Leading Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low‐grade gliomas represent a diverse category of central nervous system tumors, characterized by considerable variability in prognosis. Metabolic reprogramming, particularly lactate metabolism, has been associated with the tumor immune microenvironment; however, the prognostic significance of the related genes in LGG is still not well understood. This study used TCGA and CGGA cohorts to perform consensus clustering based on genes involved in lactate metabolism. A predictive model was constructed using differential analysis, Cox regression, and LASSO methods. The model's association with immune cell infiltration, TMB, and drug responsiveness was also evaluated. The function of the key gene PLA2G2A was validated using RT‐qPCR, Western blot, immunofluorescence, ELISA, CCK‐8, Transwell assays, and mouse tumorigenesis experiments. Consensus clustering classified LGG into two distinct subtypes, each showing significant variations in survival and immune profiles. The three‐gene signature ( VAV3 , TNFRSF12A , PLA2G2A ) effectively distinguished high‐risk from low‐risk patients, demonstrating high predictive accuracy in both TCGA and CGGA datasets. Patients categorized as high‐risk showed reduced immune infiltration, increased TMB, and a worse prognosis. Additionally, they showed increased sensitivity to tyrosine kinase inhibitors and platinum‐based therapies. Functional experiments showed that PLA2G2A was highly expressed in gliomas, and its downregulation notably reduced tumor cell proliferation, migration, invasion, and growth in vivo, while reversing the epithelial‐mesenchymal transition. This study proposes and validates a novel three‐gene prognostic model that reflects the metabolic‐immune interactions in LGG, predicts patient prognosis, and suggests potential therapeutic targets. The functional validation of PLA2G2A further underscores its potential as a therapeutic biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaGene Expression Regulation, NeoplasticBrain NeoplasmsLactic AcidHumansAnimalsPrognosisMiceTumor MicroenvironmentBiomarkers, TumorFemaleCell Line, Tumor

Stichwörter der Autor:innen

PLA2G2Aimmune microenvironmentlactate metabolism‐immune regulation‐related geneslow‐grade gliomaprognostic modeltumor mutation burden

Substanzen

Lactic AcidBiomarkers, Tumor

Autor:innen und Institutionen

  • Ningbo Key Laboratory of Nervous System and Brain Function, Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.

ORCID-Profile: Enhao Zhang, Yi Huang

Förderung

  • Ningbo Top Medical and Health Research Program
  • Ningbo Natural Science Foundation
  • Ningbo Municipal Youth Science and Technology Innovation Leading Talent Project
  • Natural Science Foundation of Ningbo Municipality

Zitieren

APA

Zhang, E., Wei, L., Ren, H., Zhang, J., Yang, H., Sun, M., Gao, X., & Huang, Y. (2026). Lactate Metabolism‐Immune Regulation‐Related Gene Signature in Lower‐Grade Gliomas: Prognostic Model Development and Immune Characterization. The FASEB Journal. https://doi.org/10.1096/fj.202503738rr

Vancouver

Zhang E, Wei L, Ren H, Zhang J, Yang H, Sun M, et al. Lactate Metabolism‐Immune Regulation‐Related Gene Signature in Lower‐Grade Gliomas: Prognostic Model Development and Immune Characterization. The FASEB Journal. 2026. doi:10.1096/fj.202503738rr

BibTeX
@article{Zhang2026,
  author = {Zhang, Enhao and Wei, Liangzhe and Ren, He and Zhang, Jianfei and Yang, Hongqiao and Sun, Meng and Gao, Xiang and Huang, Yi},
  title = {Lactate Metabolism‐Immune Regulation‐Related Gene Signature in Lower‐Grade Gliomas: Prognostic Model Development and Immune Characterization},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202503738rr}
}
Kostenlos starten →